dry age-related macular degeneration
Conditions
Interventions
Fu's subcutaneous needling group:Fu's subcutaneous needling group with oral Vitamin C and vitamin E supplements
Control group:oral Vitamin C and vitamin E supplements
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
50 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1) Age between 50 and 85 years old with no gender restrictions; 2) Meets the diagnostic criteria for dry age-related macular degeneration (AMD) as outlined in the 2023 Chinese Clinical Practice Guidelines for Age-Related Macular Degeneration; 3) Both monocular and binocular cases of dry AMD are included. For patients with bilateral lesions the experimental group is based on the patient's preferred eye (if both eyes are preferred the average of the data collected from both eyes is included in the analysis); 4) Participants must voluntarily consent and sign an informed consent form and be willing to cooperate with follow-up visits.
Exclusion criteria
Exclusion criteria: 1) Serious eye diseases that significantly affect the condition of the fundus excluding dry macular degeneration including fundus lesions such as fundus hemorrhage and wet macular degeneration; or concomitant eye diseases requiring immediate treatment such as acute glaucoma; severe opacity of the refractive media such as mature cataracts; 2) In distance vision testing the patient cannot discern the direction of the largest character at a distance of 1 meter from the distance vision chart; 3) Participants who have undergone eye surgery within the past six months; 4) Participants with non-ophthalmic conditions that may severely affect vision such as large-area cerebral infarction cerebral hemorrhage diabetes thyroid eye disease vitamin A deficiency or Sjögren's syndrome; 5) Pregnant or lactating women; 6) Participants with severe anemia renal failure acute phase of cardiovascular disease implanted cardiac pacemaker thrombocytopenia or other hematological conditions with a high risk of severe subcutaneous bleeding or requiring skin puncture; 7) Participants who have taken medications or consumed foods that affect ocular blood supply within the past week such as caffeine atropine or other treatments for macular degeneration; 8) Participants who require contact lenses.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Best Corrected Visual Acuity ; | — |
Secondary
| Measure | Time frame |
|---|---|
| central macular thickness;Choroid Thickness;vessel density;Foveal Avascular Zone;Best Corrected Visual Acuity;Visual Function Questionnaire 25;Visual field; | — |
Countries
China
Contacts
Public ContactJian Sun
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed